scispace - formally typeset
J

Jonas Manjer

Researcher at Lund University

Publications -  384
Citations -  26240

Jonas Manjer is an academic researcher from Lund University. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 84, co-authored 369 publications receiving 23177 citations. Previous affiliations of Jonas Manjer include Uppsala University & Malmö University.

Papers
More filters
Journal ArticleDOI

Parity and age at first childbirth in relation to the risk of different breast cancer subgroups

TL;DR: In this paper, the authors examined parity and age at first childbirth, in relation to the risk of specific breast cancer subgroups and concluded that parity was associated with an overall increased risk of breast cancer, although not statistically significant (the relative risk was 1.39 with a 95% confidence interval of 0.92-2.08).
Journal ArticleDOI

Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3)

Joyce Y. Huang, +63 more
TL;DR: It is demonstrated that components of the tryptophan–kynurenine pathway with immunomodulatory effects are associated with risk of lung cancer overall, especially for current smokers.
Journal ArticleDOI

A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk

Ruth C. Travis, +76 more
- 01 Jan 2019 - 
TL;DR: In this article, the authors examined the association between prediagnostic concentrations of 25-hydroxyvitamin D [25(OH)D] and 1,25-dihydroxyv vitamin D [1,25 (OH)2D], and the risk of prostate cancer overall and by tumor characteristics.
Journal ArticleDOI

Alcohol drinking and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

TL;DR: The findings suggest no association between alcohol intake and endometrial cancer risk is found.
Journal ArticleDOI

Validation of Plasma Proneurotensin as a Novel Biomarker for the Prediction of Incident Breast Cancer

TL;DR: Fasting plasma proneurotensin was significantly associated with the development of breast cancer in the MPP study as well, and warrants further investigation as a blood-based marker for early breast cancer detection.